GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Searle Co Ltd (KAR:SEARL) » Definitions » Cash From Other Investing Activities

The Searle Co (KAR:SEARL) Cash From Other Investing Activities : ₨8,962 Mil (TTM As of Mar. 2025)


View and export this data going back to 1993. Start your Free Trial

What is The Searle Co Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

The Searle Co's cash from other investing activities for the three months ended in Mar. 2025 was ₨8,851 Mil. It means The Searle Co received ₨8,851 Mil from other investing activities. The Searle Co's cash from other investing activities for the trailing twelve months (TTM) ended in Mar. 2025 was ₨8,962 Mil.

The Searle Co Cash From Other Investing Activities Historical Data

The historical data trend for The Searle Co's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Searle Co Cash From Other Investing Activities Chart

The Searle Co Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash From Other Investing Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only -174.95 -561.38 -601.57 -173.76 -110.46

The Searle Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash From Other Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.05 123.60 -5.06 -7.96 8,850.96

The Searle Co Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨8,962 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Searle Co Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of The Searle Co's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

The Searle Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Searle Co Ltd (KAR:SEARL) » Definitions » Cash From Other Investing Activities
Comparable Companies
KAR:AGP KAR:CPHL KAR:MACTER KAR:FEROZ KAR:ABOT KAR:GLAXO ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507
Traded in Other Exchanges
N/A
Address
Tipu Sultan Road, Plot No. 1, One IBL Centre, 2nd Floor, Block 7 and 8, D.M.C.H.S, Off Shahra-e-Faisal, Karachi, SD, PAK, 75530
Website
https://www.searlecompany.com
The Searle Co Ltd is a pharmaceutical company. It is principally engaged in the manufacture of pharmaceutical and other consumer products. The company manufactures pharmaceutical products like Hydryllin, Extor, Nuberol, Forte, Peditral, Selanz SR, Tramal, and other products. Its pharmaceutical product range covers the therapeutic areas of cardiovascular, antibiotics, nutrition, respiratory care, gastroenterology, oncology, hepatology, neurology and psychiatry, probiotics, antibiotics, and nutritional care.

The Searle Co Headlines

No Headlines